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Nearly 97% of the human genome is composed of noncoding DNA, which varies from one species to another. Changes in these
sequences often manifest themselves in clinical and circumstantial malfunction. Numerous genes in these non-protein-coding
regions encode microRNAs, which are responsible for RNA-mediated gene silencing through RNA interference (RNAi)-like path-
ways. MicroRNAs (miRNAs), small single-stranded regulatory RNAs capable of interfering with intracellular messenger RNAs
(mRNAs) with complete or partial complementarity, are useful for the design of new therapies against cancer polymorphisms and
viral mutations. Currently, many varieties of miRNA are widely reported in plants, animals, and even microbes. Intron-derived
microRNA(Id-miRNA)isanewclassofmiRNAderivedfromtheprocessingofgeneintrons.TheintronicmiRNArequirestype-II
RNA polymerases (Pol-II) and spliceosomal components for their biogenesis. Several kinds of Id-miRNA have been identiﬁed in
C elegans, mouse, and human cells; however, neither function nor application has been reported. Here, we show for the ﬁrst time
that intron-derived miRNAs are able to induce RNA interference in not only human and mouse cells, but in also zebraﬁsh, chicken
embryos, and adult mice, demonstrating the evolutionary preservation of intron-mediated gene silencing via functional miRNA
in cell and in vivo. These ﬁndings suggest an intracellular miRNA-mediated gene regulatory system, ﬁne-tuning the degradation
of protein-coding messenger RNAs.
Copyright © 2006 Shi-Lung Lin et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
The ﬁrst microRNA (miRNA) molecules, lin-4 and let-7,
were identiﬁed in 1993 [1]. Since then there have been rapid
advances in small RNA research, with progress in identifying
moremiRNAsandunderstandingtheirbiogenesis,function-
ality and target gene regulation. These early miRNAs were
located in the noncoding regions between genes and tran-
scribed by unidentiﬁed promoters; these are intergenic miR-
NAs. Most miRNAs studied at this stage were recognized as
intergenic miRNA until 2003, when Ambros et al [1] discov-
ered some tiny noncoding RNAs derived from the intron re-
gions of gene transcripts.
In the meantime, Lin et al [1] demonstrated the bio-
genetic and gene silencing mechanisms of these intron-
derivedmiRNAs,providingtheﬁrstfunctionalevidencefora
new miRNA category: intronic miRNA. As shown in Table 1,
several intronic miRNA molecules have been identiﬁed in C
elegans,mouse,andhumangenomes[1–3]andsomeoftheir
functions have been related to RNA interference (RNAi).
Introns occupy the largest proportion of noncoding se-
quences in the protein-coding DNA of a genome. The tran-
scription of the genomic protein-coding DNA generates
precursormessengerRNA(pre-mRNA),whichcontainsfour
major parts including the 5 -untranslated region (UTR),
the protein-coding exon, the noncoding intron, and the
3 -UTR. Broadly speaking, both the 5 -a n d3  -UTR can
be seen as a kind of intron extension; however, their pro-
cessing during mRNA translation is diﬀerent from the in-
tron located between two protein-coding exons, termed
the in-frame intron. The in-frame intron can range up to
thirty or so kilobases and was initially thought to be a
huge genetic waste in gene transcripts. Recently, this mis-
conception was corrected by the observation of intronic
miRNA. miRNA is usually about 18–25 oligonucleotides
in length and is capable of either directly degrading its
intracellular messenger RNA (mRNA) target or suppress-
ing the protein translation of its targeted mRNA, depend-
ing on the complementarity between the miRNA and its
target. In this way, the intronic miRNA is similar struc-
turally and functionally to the previously described inter-
genic miRNAs, but diﬀers from them in its unique require-
ment for Pol-II and RNA splicing components for biogen-
esis [2, 4, 5]. Approximately 10 ∼ 30% of a spliced in-
tron is exported into the cytoplasm with a moderate half-life
[6].2 Journal of Biomedicine and Biotechnology
Table 1
miRNA Species Host gene (intron) (#) Target gene(s)
miR-2a, -b2 Worm Spi
miR-7b Mammal Pituitary gland speciﬁc factor 1A
(2) [NM174947]
Paired mesoderm homeobox
protein 2b; HLHm5
miR-10b Mammal Homeobox protein HOX-4 (4)
miR-11 Drosophila E2F
miR-13b2 Drosophila CG7033
miR-15b, -16-2 Mammal Chromosome-associated
polypeptide C
miR-25, -93, -106b Mammal CDC47 homolog (13)
miR-26a1, -26a2, -26b Vertebrate Nuclear LIM interactor-interacting
factor 1, 2, 3
miR-28 Human
LIM domain-containing preferred
translocation parterner in lipoma
[NM005578]
miR-30c1, -30e Mammal Nuclear transcription factor Y
subunit γ (5)
Transcription factor HES-1; PAI-1
mRNA-binding protein
miR-33 Vertebrate Sterol regulatory element binding
protein-2 (15)
RNA-dependent helicase p68;
NAG14 protein
miR-101b Human RNA 3 -terminal phospate
cyclase-like protein (8)
miR-103, -107 Human Pantothenate kinase 1, 2, 3
miR-105-1, -105-2, -224 Mammal
γ-aminobutyric-acid receptor α-3
subunit precursor, epsilon
subunit precursor
miR-126, -126∗ Mammal EGF-like, Notch4-like, NEU1
protein (6) [NM178444]
miR-128b Mammal cAMP-regulated phospho-protein
21 (11)
miR-139 Mammal cGMP-dependent 3 ,5 -cyclic
phosphodiesterase (2)
miR-140 Human NEDD4-like ubiquitin-protein
ligase WWP2 (15)
miR-148b Mammal Coatomer ζ-1 subunit
miR-151 Mammal
miR-152 Human Coatomer ζ-2 subunit N-myc proto-oncogene protein;
noggin precursor
miR-153-1, -153-2 Human Protein-tyrosine phosphatase N
precursors
miR-208 Mammal Myosin heavy chain, cardiac
muscle α isoform (28)
miR-218-1, -218-2 Human Slit homolog proteins
[NM003062]
RNA interference (RNAi) is a posttranscriptional gene
silencing mechanism in eukaryotes, which can be triggered
by small RNA molecules such as microRNA (miRNA) and
small interfering RNA (siRNA). These small RNA molecules
usuallyfunctionasgenesilencers,interferingwithintracellu-
lar expression of genes either completely or partially comple-
mentary to the small RNAs. In principle, siRNAs are double-
stranded RNAs capable of degrading target gene transcriptsShi-Lung Lin et al 3
with almost perfect complementarity [7, 8]. Unlike the strin-
gent complementarity of siRNAs to their RNA targets, miR-
NAs are single-stranded and able to pair with target RNAs
that have partial complementarity to the miRNAs [9, 10].
Numerous natural miRNAs are derived from hairpin-like
RNA precursors in almost all eukaryotes, including yeast
(Schizosaccharomyces pombe), plant (Arabidopsis spp), nema-
tode (Caenorhabditis elegans), ﬂy (Drosophila melanogaster),
mouse, and human, functioning as a defense against viral
infections and allowing regulation of gene expression dur-
ing development [11–21]. In contrast, natural siRNAs are
abundantinplantsandrelativelysimpleanimals(wormsand
ﬂies), but are rarely seen in mammals [10]. Because of the
widespread presence of miRNAs in eukaryotes, these small
RNAs have recently been used to design novel therapeutics
forcancersandviralinfections[4,22].Infact,gene-silencing
mechanisms involving miRNA may be an intracellular de-
fense system for eliminating undesired transgenes and for-
eign RNAs, such as viral infections and retrotransposon ac-
tivities [22, 23].
DeﬁnitionofmiRNA:Biogenesis
The deﬁnition of intronic miRNAs is based on two fac-
tors; ﬁrst, they must share the same promoter with their
encoded target genes, and second, they are spliced out of
the transcript of such encoded genes and further processed
intomaturemiRNAs.Althoughsomeofthecurrentlyknown
miRNAs are encoded in the genomic intron region of a
given gene but in the opposite orientation to the gene tran-
script (palindrome), such miRNAs are not intronic miR-
NAs because they neither share the same promoter with
the gene nor need to be released from the gene transcript
by RNA splicing. For the transcription of such palindromic
miRNAs, the promoters are located in the antisense di-
rection to the gene, likely using the gene transcript as a
potential target for the antisense miRNA. A good exam-
ple is let-7c, which is an intergenic miRNA located in the
antisense region of a gene intron. Current computer pro-
grams for miRNA prediction cannot distinguish the intronic
miRNA from the intergenic miRNA. Because intronic miR-
NAs are encoded in the gene transcript precursors (pre-
mRNA) and share the same promoter with the encoded gene
transcripts, the miRNA prediction programs tend to clas-
sify the intronic miRNAs along with the intergenic miR-
NAs located in the exonic regions. However, in view of their
diﬀerent biogenic mechanisms, these two types of miRNA
may have diﬀerent gene-regulatory functions in the adjust-
ment of cellular physiology. Thus, a miRNA-prediction pro-
gram utilizing a database of noncoding sequences located
in the protein-coding pre-mRNA regions is urgently needed
for thoroughly screening and understanding the distribu-
tion and variety of hairpin-like intronic miRNAs in the
genomes.
The process of miRNA biogenesis in vertebrates involves
ﬁve steps (Figure 1). First, a long primary precursor miRNA
(pri-miRNA) is excised, probably by RNA polymerase type-
II (Pol-II) [2, 24]. Second, the long pri-miRNA is further
excised by Drosha-like RNase III endonucleases or spliceo-
somal components, depending on the origin of the pri-
miRNA either in an exon or an intron, respectively [2, 25],
toformamatureprecursormiRNA(pre-miRNA),andthird,
the pre-miRNA is exported out of the nucleus by Ran-GTP
and the receptor Exportin-5 [26, 27]. In the cytoplasm,
Dicer-like nucleases cleave the pre-miRNA to form mature
miRNA. Lastly, the mature miRNA is incorporated into a ri-
bonuclear particle (RNP), which becomes the RNA-induced
gene silencing complex (RISC), capable of executing RNAi-
related gene silencing [28, 29]. Although an in vitro model
of siRNA-associated RISC assembly has been generated, the
link between the ﬁnal miRNA maturation and RISC assem-
bly remains to be determined. The characteristics of Dicer
and RISC are distinctly diﬀerent in the siRNA and miRNA
mechanisms [30]. In zebraﬁsh, we have recently observed
that the stem-loop structure of pre-miRNA is involved in
strand selection for mature miRNA during RISC assembly.
These ﬁndings suggest that the duplex structure of siRNA
may not be essential for the assembly of miRNA-associated
RISC in vivo. The biogeneses of miRNA and siRNA seem
to be very similar; however, the miRNA mechanisms pre-
viously proposed were based on the model of siRNA. In
contrast, it will be necessary to distinguish the individual
properties and diﬀerences in these two types of RNAs in or-
der to understand the evolutionary and functional relation-
ship of these gene-silencing pathways. In addition, the diﬀer-
ences may provide a clue for understanding the prevalence
of native siRNAs in invertebrates compared to that in mam-
mals.
The proposed research will generate data from several
transgenic zebraﬁsh lines. It is our explicit intention that
these data will be submitted in a readily accessible pub-
lic database in the ZFIN website. All eﬀorts will be made
to rapidly release data through publication of results as
quickly as possible to analyze the experiments. Data used
in publications will be released in a timely manner. ZFIN
data will be made accessible through a public site that allows
querying as has been set up for a similar project.
IntronicmiRNAanddisease
The majority of human gene transcripts contain introns,
phylogenetically conserved to a greater or lesser degree.
Changes in these non-protein-coding sequences are fre-
quently observed in clinical malfunction such as myotonic
dystrophy and fragile X syndrome.
Numerous introns encode miRNAs which are involved
in RNAi-related chromatin silencing mechanisms. Over 90
intronic miRNAs have been identiﬁed using the bioinfor-
matic approaches to date, but the function of the vast ma-
jority of these molecules remains to be determined [3]. Ac-
cording to the strictly expressive correlation of intronic miR-
NAs with their encoded genes, one may speculate that the
levels of condition-speciﬁc, time-speciﬁc, and individual-
speciﬁc gene expression are determined by the inﬂuences
of distinctive miRNAs on single or multiple gene modula-
tion. This interpretation accounts for the heterogeneity of4 Journal of Biomedicine and Biotechnology
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Figure 1: Comparison of biogenesis and RNAi mechanisms among siRNA, intergenic (exonic) miRNA, and intronic miRNA. siRNA is
likely formed by two perfectly complementary RNAs transcribed from two diﬀerent promoters (remaining to be determined) and further
processing into 19–22bp duplexes by the RNase III-familial endonuclease, Dicer. The biogenesis of intergenic miRNAs, for example, lin-4
and let-7, involves a long transcript precursor (pri-miRNA), which is probably generated by Pol-II or Pol-III RNA promoters, while intronic
miRNAs are transcribed by the Pol-II promoters of its encoded genes and coexpressed in the intron regions of the gene transcripts (pre-
mRNA). After RNA splicing and further processing, the spliced intron may function as a pri-miRNA for intronic miRNA generation. In the
nucleus, the pri-miRNA is excised by Drosha RNase to form a hairpin-like pre-miRNA template and then exported to the cytoplasm for
further processing by Dicer∗ to form mature miRNA. The Dicers for siRNA and miRNA pathways are diﬀerent. All three small regulatory
RNAs are ﬁnally incorporated into an RNA-induced silencing complex (RISC), which contains either the strand of siRNA or the single-
strand of miRNA. The action of miRNA is considered to be more speciﬁc and less adverse than that of siRNA because only one strand is
involved. siRNA primarily triggers mRNA degradation, whereas miRNA can induce either mRNA degradation or suppression of protein
synthesis depending on the sequence complementarity to the target gene transcripts.
genetic expression of various traits; dysregulation will re-
sult in genetic disease. For instance, monozygotic twins fre-
quentlydemonstrateslight,butdeﬁnitelydistinguishing,dif-
ferences in disease susceptibility and behavior. For example,
a long CCTG expansion in intron 1 of the zinc ﬁnger protein
ZNF9 gene has been correlated with type 2 myotonic dystro-
phy in whichever twin exhibits the higher susceptibility [31].
Sincetheexpansionmotifboundwithhighaﬃnitytocertain
RNA-binding proteins, an interfering role of intron-derived
expansion fragments is suggested. Another more-established
example involving pathogenic intronic expansion fragments
is fragile X syndrome, which accounts for about 30% of
human inherited mental retardation. Intronic CGG repeat
(rCGG) expansion in the 5 -UTR of the FMR1 gene is the
causative mutation in 99% of individuals with fragile X syn-
drome [32]. FMR1 encodes an RNA-binding protein, FMRP,
which is associated with polyribosome assembly in an RNP-
dependent manner and is capable of suppressing translation
throughanRNAi-likepathway.FMRPalsocontainsanuclear
localization signal (NLS) and a nuclear export signal (NES)
for shuttling certain mRNAs between the nucleus and cyto-
plasm [33]. Jin et al proposed that RNAi-mediated methy-
lation occurs in the CpG region of the FMR1 rCGG expan-
sion, which is targeted by a hairpin RNA derived from the 3 -
UTRoftheFMR1expandedalleletranscript[32].TheDicer-
processed hairpin RNA triggers the formation of an RNA-
induced initiator of transcriptional gene silencing (RITS) on
the homologous rCGG sequences and leads to heterochro-
matin repression of the FMR1 locus. These examples suggest
that natural evolution gives rise to more intronic complexity
and variety in higher animals and plants, allowing the coor-
dination of their vast gene expression libraries and interac-
tions. Any dysregulation of miRNA derivation from introns
maythenleadtogeneticdiseaseinvolvingintronicexpansion
or deletion, such as myotonic dystrophy and fragile X mental
retardation.Shi-Lung Lin et al 5
Man-madeintronicmiRNA
To understand the disease caused by the dysregulation of in-
tronic miRNA, an artiﬁcial expression system is needed to
recreate the function and mechanism of miRNA in vitro and
in vivo. The same approach may be used to design and de-
velop therapies. Several vector-based RNAi expression sys-
tems have been developed, using type-III RNA polymerase
(Pol-III)-directed transcription activities, to generate more
stable RNAi eﬃcacy and lower interferon-related toxicity in
several cell lines in vitro [34–37]. For gene therapy in vivo, a
functional gene is preferably delivered into an animal or hu-
man being by expression-competent vector vehicles, such as
retroviralvector,lentiviralvector,adenoviralvector,andade-
noassociated viral (AAV) vector. The main purpose of these
vector-based approaches is to maintain long-term and con-
sistent gene modulation. Although some studies [38, 39]a t -
tempting to use the Pol-III-directed RNAi system have suc-
ceeded in maintaining constant gene silencing eﬃcacy in
vivo, their delivery strategies failed to target a speciﬁc cell
population due to the ubiquitous existence of Pol-III activity
in all cell types. Moreover, the requirement of using Pol-III
RNA promoters, for example, U6 and H1, for small RNA ex-
pression is another problem. Because the read-through side-
eﬀect of Pol-III occurs on a short transcription template
in the absence of proper termination, large RNA products
longer than the desired 18–25 base pairs (bp) can be synthe-
sized and cause unexpected interferon cytotoxicity [40, 41].
Such a problem can also result from competition between
the Pol-III promoter and another vector promoter (ie, LTR
and CMV promoters). We and others [42] have found that
a high dosage of siRNA (eg, > 250nM in human T cells)
caused strong cytotoxicity similar to that of long double-
stranded dsRNA [42, 43]. This toxicity is due to the double-
stranded structure of siRNA and dsRNA, which activates
interferon-mediated nonspeciﬁc RNA degradation and pro-
grammed cell death through signaling via the PKR and 2–5A
systems. It is well known that the interferon-induced protein
kinase PKR can trigger cell apoptosis, while activation of the
interferon-induced 2 ,5  -oligoadenylate synthetase (2–5A)
system leads to extensive cleavage of single-stranded RNAs
(ie, mRNAs) [44]. Both the PKR and 2–5A systems contain
dsRNA-binding motifs which are highly conserved, but these
motifs do not bind either single-strand RNAs or RNA-DNA
hybrids. These disadvantages limit the use of Pol-III-based
RNAi vector systems for therapeutic purposes.
The intron-derived miRNA system is activated in a spe-
ciﬁc cell type under the control of type-II RNA polymerases
(Pol-II)-directed transcriptional machinery. To overcome
Pol-III-mediated siRNA side eﬀects, we have successfully de-
velopedanovelPol-II-basedmiRNAbiogenesisstrategy,em-
ploying intronic miRNA molecules [2] to knock down more
than 85% of selected oncogene function or viral genome
replication [45, 46]. Because of the ﬂexibility in binding to
partially complementary mRNA targets, miRNA can serve
as an anticancer drug or vaccine, a major breakthrough in
the treatment of cancer polymorphisms and viral mutations.
We are the ﬁrst research group to discover the biogenesis of
miRNA-like precursors from the 5 -proximal intron regions
of gene transcripts (pre-mRNA) produced by the mam-
malian Pol-II. Depending on the promoter of the miRNA-
encodedgenetranscript,intronicmiRNAiscoexpressedwith
its encoding gene in a speciﬁc cell population, which ac-
tivates the promoter and expresses the gene. It has been
noted that a spliced intron was not completely digested into
monoribonucleotides for transcriptional recycling since ap-
proximately 10–30% of the intron was found in the cyto-
plasm with a moderate half life [6, 47]. This type of miRNA
generation relies on the coupled interaction of nascent Pol-
II-mediated pre-mRNA transcription and intron excision,
occurring within certain nuclear regions proximal to ge-
nomic perichromatin ﬁbrils [46, 48, 49]. After Pol-II RNA
processing and splicing excision, some of the intron-derived
miRNA fragments can form mature miRNAs and eﬀectively
silence the target genes through the RNAi mechanism, while
the exons of pre-mRNA are ligated together to form a ma-
ture mRNA for protein synthesis (Figure 2(a))[ 2]. Because
miRNAs are single-stranded molecules insensitive to PKR-
and 2–5A-induced interferon systems, the Pol-II-mediated
miRNA generation can avoid the cytotoxic eﬀects of dsRNA
and siRNA in vitro and in vivo. These ﬁndings indicate new
functions for mammalian introns in intracellular miRNA
generation and gene silencing, which can be used both as
tools for the analysis of gene functions and the development
of gene-speciﬁc therapeutics against cancers and viral infec-
tions.
Using artiﬁcial introns carrying hairpin-like miRNA pre-
cursors(pre-miRNA),wehavesuccessfullygeneratedmature
miRNA molecules with full capacity for triggering RNAi-
like gene silencing in human prostate cancer LNCaP, hu-
man cervical cancer HeLa, and rat neuronal stem HCN-A94-
2 cells [2, 45]. As shown in Figure 2(b), the artiﬁcial in-
tron (SpRNAi) was cotranscribed within a precursor mes-
senger RNA (pre-mRNA) by Pol-II and cleaved out of the
pre-mRNA by RNA splicing. Then the spliced intron con-
taining the pre-miRNA was further processed into mature
miRNAcapableoftriggeringRNAi-relatedgene-silencingef-
fects. Utilizing this artiﬁcial miRNA model, we have tested
various pre-miRNA constructs, and observed that the pro-
ductionofintron-derivedmiRNAfragmentsoriginatedfrom
the5 -proximityoftheintronsequencebetweenthe5 -splice
site and the branching point. These miRNAs were able to
trigger strong suppression of genes possessing more than
70% complementarity to the miRNA sequences, whereas
nonhomologous miRNA intron, that is, empty intron with-
out the pre-miRNA insert, with an oﬀ-target miRNA in-
sert (negative control) and splicing-defective intron, showed
no silencing eﬀects on the targeted gene. The same results
can also be reproduced in the zebraﬁsh by directing the
miRNA against target EGFP expression (Figure 2(c)), indi-
cating the consistent preservation of the intronic miRNA
biogenesis system in vertebrates. Furthermore, no eﬀect was
detected on oﬀ-target genes, such as RGFP and β-actin, sug-
gesting the high speciﬁcity of miRNA-directed RNA interfer-
ence (RNAi). We have conﬁrmed the identity of the intron-
derived miRNA, which comprised about 18–25 nucleotides6 Journal of Biomedicine and Biotechnology
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Figure 2:BiogenesisandfunctionofintronicmiRNA.(a)ThenativeintronicmiRNAiscotranscribedwithaprecursormessengerRNA(pre-
mRNA) by Pol-II and cleaved out of the pre-mRNA by an RNA splicing machinery, the spliceosome. The spliced intron with hairpin-like
secondary structure is further processed into mature miRNA capable of triggering RNAi eﬀects, while the ligated exons become a mature
messenger RNA (mRNA) for protein synthesis. (b) We designed an artiﬁcial intron containing pre-miRNA, namely SpRNAi, mimicking
the biogenesis of the native intronic miRNA. (c) When a designed miR-EGFP(280–302)-stemloop RNA construct was tested in the EGFP-
expressing Tg(UAS:gfp) zebraﬁsh, we detected a strong RNAi eﬀect only on the target EGFP (lane 4). No detectable gene-silencing eﬀect was
observed in other lanes; from left to right: 1, blank vector control (Ctl); 2, miRNA-stemloop targeting HIV-p24 (mock); 3, miRNA without
stemloop (anti); and 5, stemloop-miRNA∗ complementary to the miR-EGFP(280–302) sequence (miR∗). The oﬀ-target genes, such as
vector RGFP and ﬁsh actin, were not aﬀected, indicating the high target speciﬁcity of miRNA-mediated gene silencing. (c) Three diﬀerent
miR-EGFP(280–302) expression systems were tested for miRNA biogenesis; from left to right: 1, vector expressing intron-free RGFP, no pre-
miRNA insert; 2, vector expressing RGFP with an intronic 5 -miRNA-stemloop-miRNA∗-3  insert; and 3, vector similar to the 2 construct
but with a defected 5 -splice site in the intron. In Northern blot analysis probing the miR-EGFP(280–302) sequence, the mature miRNA was
released only from the spliced intron resulting from the vector 2 construct in the cell cytoplasm.
(nt), approximately the length of the newly identiﬁed in-
tronic miRNAs in Ce l e g a n s . Moreover, the intronic small
RNAs isolated by guanidinium-chloride ultracentrifugation
canelicitstrong,butshort-lived,gene-silencingeﬀectsonthe
homologous genes in transfected cells, indicating a reversible
RNAi eﬀect. Thus, the long-term (> 1 month) gene-silencing
eﬀect that we observed in vivo, using the Pol-II-mediated
intronic miRNA system, is likely maintained by constitutive
miRNA production from the vector rather than the stability
of the miRNA.
The components of the Pol-II-mediated SpRNAi system
include several consensus nucleotide elements consisting ofShi-Lung Lin et al 7
Pre-mRNA construct with SpRNAi:
5
￿-promoter exon 1 - artiﬁcial intron (SpRNAi) - exon 2 3
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Figure 3: Schematic construct of the artiﬁcial SpRNAi intron in a recombinant gene SpRNAi-RGFP for intracellular expression and pro-
cessing. The components of the Pol-II-mediated SpRNAi system include several consensus nucleotide elements consisting of a 5 -splice site,
a branch-point domain (BrP), a poly-pyrimidine tract (PPT), a 3 -splice site, and a pre-miRNA insert located between the 5 -splice site
and the BrP domain. The expression of the recombinant gene is under the regulation of either a mammalian Pol-II RNA promoter or a
compatible viral promoter for cell-type-speciﬁc eﬀectiveness. Mature miRNA molecules are released from the intron by RNA splicing and
further Dicer processing.
a5  -splice site, a branch-point domain, a poly-pyrimidine
tract, and a 3 -splice site (Figure 3). Additionally, a pre-
miRNA insert sequence is placed within the artiﬁcial intron
betweenthe5 -splicesiteandthebranch-pointdomain. This
portion of the intron would normally form a lariat struc-
ture during RNA splicing and processing. We now know
that spliceosomal U2 and U6 snRNPs, both helicases, may
be involved in the unwinding and excision of the lariat RNA
fragment into pre-miRNA; however, the detailed processing
remains to be elucidated. Further, the SpRNAi contains a
translation stop codon domain (T codon) in its 3 -proximal
region to facilitate the accuracy of RNA splicing which, if
present in a cytoplasmic mRNA, would signal the diversion
of a splicing-defective pre-mRNA to the nonsense-mediated
decay (NMD) pathway and thus cause the elimination of any
unspliced pre-mRNA in the cell. For intracellular expression
of the SpRNAi, we needed to insert the SpRNAi construct
into the DraII cleavage site of a red ﬂuorescent membrane
protein (RGFP) gene from mutated chromoproteins of coral
reef Heteractis crispa. The cleavage of RGFP at its 208th nu-
cleotidesitebytherestrictionenzymeDraIIgeneratesanAG-
GN nucleotide break with three recessing nucleotides at each
end, which forms 5  and 3  splice sites, respectively, after the
SpRNAi insertion. Because this intronic insertion disrupts
the expression of functional RGFP, it becomes possible to de-
termine the occurrence of intron splicing and RGFP-mRNA
maturation through the appearance of red ﬂuorescent emis-
sion around the membrane surface of the transfected cells.
The RGFP also provides multiple exonic splicing enhancers
(ESEs) to increase RNA splicing eﬃciency.
Intron-mediatedgenesilencinginzebraﬁsh
The foregoing discussion establishes the fact that intronic
miRNAs are an eﬀective strategy for silencing speciﬁc tar-
get genes in vivo. We ﬁrst tried to determine the structural
design of pre-miRNA inserts for the best gene-silencing ef-
fect. We found that a strong structural bias exists for the se-
lection of a mature miRNA strand during the assembly of
the RNAi eﬀector, the RNA-induced gene silencing complex
(RISC). RISC is a protein: RNA complex that directs either
targetgenetranscriptdegradationortranslationalrepression
throughtheRNAimechanism.FormationofsiRNAduplexes
plays a key role in the assembly of the siRNA-associated
RISC. The two strands of the siRNA duplex are function-
ally asymmetric, but the assembly into the RISC complex
is preferential for only one strand. Such preference is deter-
mined by the thermodynamic stability of each 5 -end base-
pairing in the strand. Based on this siRNA model, the forma-
tion of miRNA and its complementary miRNA (miRNA∗)
duplex was thought to be an essential step for the assem-
bly of miRNA-associated RISC. If this were true, no func-
tional bias would be observed in the stemloop of a pre-
miRNA. Nevertheless, we observed that the stemloop of the
intronic pre-miRNA was involved in the strand selection of
a mature miRNA for RISC assembly in zebraﬁsh. In these
experiments, we constructed miRNA-expressing SpRNAi-
R G F Pv e c t o r sa sp r evi o u s l yd e s c ri b e d[ 2] and two symmetric
pre-miRNAs, miRNA-stemloop-miRNA∗ (1) and miRNA∗-
stemloop-miRNA (2), were synthesized and inserted into
the vectors, respectively. Both pre-miRNAs contained the
same double-stranded stem arm region, which was directed
against the EGFP nt 280–302 sequence. Because the in-
tronic insert region of the SpRNAi-RGFP recombined gene
is ﬂanked with a PvuI and an MluI restriction site at the
5 -a n d3  -ends, respectively, the primary insert can be eas-
ilyremovedandreplacedbyvariousgene-speciﬁcinserts(eg,
anti-EGFP)possessingcohesiveends.Byallowingachangein
the pre-miRNA inserts directed against diﬀerent gene tran-
scripts, this intronic miRNA generation system provides a
valuable tool for genetic and miRNA-associated research in
vivo.
To determine the structural preference of the designed
pre-miRNA, we have isolated the zebraﬁsh small RNAs
by mirVana miRNA isolation columns (Ambion, Austin,
TX) and then precipitated all potential miRNAs comple-
mentary to the target EGFP region by latex beads con-
taining the target RNA sequence. One full-length miRNA,
miR-EGFP(280–302), was active in the transfections of
the 5 -miRNA-stemloop-miRNA∗-3  construct, as shown
in Figure 4(a) (gray-shading sequences). Since the ma-
ture miRNA was detected only in the zebraﬁsh trans-
fected by the 5 -miRNA-stemloop-miRNA∗-3  construct,
the miRNA-associated RISC tends to preferably interact8 Journal of Biomedicine and Biotechnology
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Figure 4: Intronic miRNA-mediated gene silencing eﬀects in vivo. (a)–(c) Diﬀerent preferences for RISC assembly were observed following
the transfection of 5 -miRNA∗-stemloop-miRNA-3  (1) and 5 -miRNA-stemloop-miRNA∗-3  (2) pre-miRNA structures in zebraﬁsh, re-
spectively. (a) One mature miRNA, namely miR-EGFP(280/302), was detected in the (2)-transfected zebraﬁsh, whereas the (1)-transfection
producedanotherkindofmiRNA,miR∗-EGFP(301–281),whichwaspartiallycomplementarytothemiR-EGFP(280/302).(b)TheRNAief-
fect was only observed with the transfection of the (2) pre-miRNA, showing less EGFP (green) in (2) than in (1), while the miRNA indicator
RGFP (red) was equally present in all vector transfections. (c) Western blot analysis of the EGFP protein levels conﬁrmed the speciﬁc silenc-
ing result of (b). No detectable gene silencing was observed in ﬁsh without (Ctl) and with liposome only (Lipo) treatments. The transfection
of either a U6-driven siRNA vector (siR) or an empty vector (Vctr) without the designed pre-miRNA insert resulted in no signiﬁcant gene
silencing. (d)–(g) Silencing of endogenous β-catenin and noggin genes in chicken embryos. (d) The pre-miRNA construct and fast green
dye mixtures were injected into the ventral side of chicken embryos near the liver primordia below the heart. (e) Northern blot analysis of
extracted RNAs from chicken embryonic livers with anti-β-catenin miRNA transfections (lanes 4–6) in comparison with wild types (lanes
1–3) showed a more than 98% silencing eﬀect on β-catenin mRNA expression, while the house-keeping gene, GAPDH, was not aﬀected.
(f) Liver formation of the β-catenin knockouts was signiﬁcantly hindered (upper right 2 panels). Microscopic examination revealed a loose
structure of hepatocytes, indicating the loss of cell-cell adhesion due to breaks in adherents junctions formed between β-catenin and cell
membrane E-cadherin in early liver development. In severely aﬀected regions, feather growth in the skin close to the injection area was also
inhibited (lower right 2 panels). Immunohistochemical staining for β-catenin protein (brown) showed a signiﬁcant decrease in the feather
folliclesheaths.(g)Lowerbeakdevelopmentwasincreasedbythemandibularinjectionoftheantinogginpre-miRNAconstruct(lowerpanel)
in comparison to wild type (upper panel). Right panels showed bone (alizarin red) and cartilage (alcian blue) staining to demonstrate the
outgrowth of bone tissues in the lower beak of the noggin knockout. Northern blot analysis (small windows) conﬁrmed a ∼ 60% decrease
of noggin mRNA expression in the lower beak area.Shi-Lung Lin et al 9
with the construct (2) rather than the (1) pre-miRNA. The
greenﬂuorescentproteinEGFPexpressionwasconstitutively
drivenbytheβ-actinpromoterlocatedinalmostallcelltypes
of the zebraﬁsh, while Figure 4(b) shows that transfection
of the SpRNAi-RGFP vector into the Tg(UAS:gfp) zebraﬁsh
coexpressed the red ﬂuorescent protein RGFP, serving as a
positive indicator for miRNA generation in the transfected
cells. This approach has been successfully used in several
mouse and human cell lines to show RNAi eﬀects [2, 45].
We applied the liposome-encapsulated vector (total 60μg)
to the ﬁsh and found that the vector easily penetrated al-
most all tissues of the two-week-old zebraﬁsh larvae within
24 hours, providing fully systemic delivery of the miRNA ef-
fect. The indicator RGFP was detected in both of the ﬁsh
transfectedby either5 -miRNA∗-stemloop-miRNA-3  or 5 -
miRNA-stemloop-miRNA∗-3  pre-miRNA, whereas the si-
lencing of target EGFP expression (green) was observed only
in the ﬁsh transfected by the 5 -miRNA-stemloop-miRNA∗-
3  pre-miRNA (Figures 4(b)–4(c)). The suppression level in
the gastrointestinal (GI) tract was somewhat lower, proba-
bly due to the high RNase activity in this region. Because
thermostability in the 5  end of the siRNA duplexes result-
ing from both of the designed pre-miRNA molecules is the
same,wesuggestthatthestemloopofpre-miRNAisinvolved
in strand selection of mature miRNA during RISC assembly.
Given that the cleavage site of Dicer in the stem arm deter-
mines the strand selection of mature miRNA [25], the stem-
loop may function as a determinant for the recognition of
a special cleavage site. Therefore, the heterogeneity of stem-
loop structures among various species may help to explain
the prevalence of native miRNA in vertebrates over inverte-
brates.
Intron-mediatedgenesilencingin
chickenembryos
T h ei nv i v om o d e lo fc h i c k e ne m b r y o sh a sb e e nw i d e l yu t i -
lized in developmental biology, signal transduction, and ﬂu
vaccinedevelopment. Wehavesuccessfullydemonstratedthe
feasibility of localized gene silencing in vivo by the intronic
miRNAapproachandalsodiscoveredthattheinteractionbe-
tween pre-mRNA and genomic DNA may be essential for
miRNA biogenesis. As an example, the β-catenin gene was
selected because its products play a critical role in develop-
ment[50].β-cateninisinvolvedinthegrowthcontrolofskin
and liver tissues in chicken embryos. The loss-of-function of
β-catenin is lethal in transgenic animals. As shown in Fig-
ures 4(d)–4(g), experimental results demonstrated that the
miRNAs derived from a long mRNA-DNA hybrid construct
(≥ 150bp) were capable of inhibiting β-catenin gene expres-
sionintheliverandskinofdevelopingchickenembryos.Ho-
mologous recombination between the intronic miRNA and
genomic DNA may account for a part of the speciﬁc gene-
silencing eﬀect [46]. We have demonstrated that the [P32]-
labeled DNA component of an mRNA-DNA duplex con-
structincellnuclearlysateswasintactduringtheeﬀectivepe-
riod of miRNA-induced RNA interference (RNAi) phenom-
ena, while the labeled RNA component was replaced by cold
homologues and excised into small RNA fragments within
a 3-day incubation period. Since intronic miRNA generation
reliesonacoupledinteractionofnascentPol-II-directedpre-
mRNA transcription and intron excision occurring proximal
to genomic perichromatin ﬁbrils, the above observation in-
dicates that pre-mRNA-genomic DNA recombination may
facilitate new miRNA generation by Pol-II RNA transcrip-
tion and excision for relatively long-term gene silencing. Al-
ternatively, Pol-II may function as an RNA-dependent RNA
polymerase (RdRp) for producing small interfering RNAs,
since mammalian Pol-II possesses RdRp activities [51, 52].
Thus, it appears that Pol-II-mediated RNA generation and
excisionisinvolvedinbothmRNA-DNA-derivedandintron-
derivedmiRNAbiogenesis,resultinginsingle-strandedsmall
RNAs of about 20nt, comparable to the usual sizes of Dicer-
processed miRNAs as observed in the regulation of numer-
ous developmental events.
In an eﬀort to test the pre-mRNA and genome interac-
tion theory, we performed an intracellular transfection of
the mRNA-DNA hybrid construct containing a hairpin anti-
β-catenin pre-miRNA, which was directed against the cen-
tral region of the β-catenin coding sequence (aa 306–644)
with perfect complementarity. A perfectly complementary
miRNA theoretically directs target mRNA degradation more
eﬃciently than translational repression. Using embryonic
day 3 chicken embryos, a dose of 25nM of the pre-miRNA
construct was injected into the ventral body cavity, which is
close to where the liver primordia would form (Figure 4(d)).
For eﬃc i e n td e l i v e ryi n t ot a r g e tt i s s u e s ,t h ep r e - m i R N Ac o n -
struct was mixed with the DOTAP liposomal transfection
reagent (Roche Biomedicals, Indianapolis, IN) at a ratio of
3:2. A 10% (v/v) fast green solution was concurrently added
during the injection as a dye indicator. The mixtures were in-
jected into the ventral side near the liver primordia below the
heart using heat pulled capillary needles. After injection, the
embryonic eggs were sealed with sterilized scotch tape and
incubated in a humidiﬁed incubator at 39–40◦ C until day
12 when the embryos were examined and photographed un-
der a dissection microscope. Several malformations were ob-
served, although the embryos survived without visible overt
toxicity or overall perturbation of embryo development. The
liver was the closest organ to the injection site and its pheno-
type was most dramatically aﬀected. Other regions, particu-
larly the skin close to the injection site, were also aﬀected by
the diﬀused miRNA. As shown in Figure 4(e), Northern blot
analysis for the targeted β-catenin mRNA expression in the
dissected livers showed that β-catenin expression in the wild-
type livers remained normal (lanes 1–3), whereas expression
in the miRNA-treated samples was decreased dramatically
(lanes 4–6). miRNA silencing degraded more than 98% of
β-catenin mRNA expression in the embryonic chicken, but
hadnoeﬀectonthehouse-keepinggeneGAPDHexpression,
indicating high target speciﬁcity and very limited interferon-
related cytotoxicity in vivo for the miRNA construct.
After ten days of primordial injection with the anti-β-
catenin pre-miRNA template, the embryonic chicken livers
showed enlarged and engorged ﬁrst lobes, but the sizes of
the second and third lobes of the livers were dramatically10 Journal of Biomedicine and Biotechnology
decreased (Figure 4(f)). Histological sections of normal liv-
ersshowedhepaticcordsandsinusoidalspacewithfewblood
cells.Intheanti-β-cateninmiRNA-treatedembryos,thegen-
eral architecture of the hepatic cells in lobes 2 and 3 re-
mained unchanged; however, there were islands of abnor-
mality in lobe 1. Endothelial development appeared to be
defective and blood leaked from the blood vessels. Abnor-
mal hematopoietic cells were also observed between hepato-
cytes, particularly dominated by a population of small cells
with round nuclei and scanty cytoplasm. In severely aﬀected
regions, hepatocytes were disrupted (Figure 4(f), small win-
dows) and the diﬀused miRNA also inhibited feather growth
in the skin area close to the injection site. The results showed
that the anti-β-catenin miRNA was very eﬀective in knock-
ing out targeted gene expression at a very low dose of 25nM
over a long period of time (≥ 10 days). Further, the miRNA
gene-silencing eﬀect appeared to be very speciﬁc as oﬀ-target
organs appeared normal, indicating that the small single-
stranded miRNA herein produced no generalized toxicity.
In an attempt to silence noggin expression in the mandible
beakareausingthesameapproach(Figure 4(g)),anenlarged
lower beak morphology was produced similar to what is seen
in BMP4-overexpressing chicken embryos [53, 54]. Skele-
ton staining showed outgrowth of bone and cartilage tis-
sues in the injected mandible area (Figure 4(g), right pan-
els) and Northern blot analysis further conﬁrmed that about
60% of noggin mRNA expression was knocked out in this
region (small windows). Since bone morphogenetic protein
4 (BMP4), a member of the transforming growth factor-β
(TGF-β) superfamily, is known to promote bone develop-
ment and since noggin is an antagonist of BMP2/4/7 genes,
it is not surprising to ﬁnd that our miRNA-mediated nog-
gin knockouts exhibited a morphological change resembling
the eﬀects of BMP4-overexpression as reported in chicken
and other avian models. Thus, gene silencing in the chicken
by miRNA transfection has a great potential for localized
transgene-like manipulation in developmental biology.
DevelopmentofmiRNAtherapy
The following experiments demonstrate silencing exogenous
retrovirus replication in an ex vivo cell model of patient-
extracted CD4+ T lymphocytes. Speciﬁc anti-HIV SpRNAi-
RGFPvectorsweredesignedtotargetthegag-polregionfrom
approximately nt +2113 to +2450 of the HIV-1 genome.
This region is relatively conserved and can serve as a good
target for anti-HIV treatment [55]. The viral genes located
in this target region include 3 -proximal Pr55gag polypro-
tein (ie, matrix p17 + capsid p24 + nucleocapsid p7) and
5 -proximal p66/p51pol polyprotein (ie, protease p10 + re-
verse transcriptase); all these components have critical roles
in viral replication and infectivity. During the early infec-
tionphase,theviralreversetranscriptasetranscribestheHIV
RNA genome into a double-stranded cDNA sequence, which
forms a preintegration complex with the matrix, integrase,
and viral protein R (Vpr). This complex is then transferred
to the cell nucleus and integrated into the host chromosome,
consequently establishing the HIV provirus. We hypothe-
sizedthat,althoughHIVcarriesfewreversetranscriptaseand
matrix proteins during its ﬁrst entry into host cells, the co-
suppression of Pr55gag and p66/p51pol gene expression by
miRNAs would eliminate the production of infectious viral
particles in the late infection phase. Silencing Pr55gag may
prevent the assembly of intact viral particles due to the lack
of matrix and capsid proteins, while suppression of protease
in p66/p51pol can inhibit the maturation of several viral pro-
teins. HIV expresses about nine viral gene transcripts which
encode at least 15 various proteins; thus, the separation of a
polyprotein into individual functional proteins requires the
viral protease activity. As shown in Figure 5, this therapeutic
approach is feasible [22, 43].
The anti-HIV SpRNAi-RGFP vectors were tested in
CD4+ T lymphocyte cells from HAART-treated, HIV-sero-
positive patients. Because only partial complementarity be-
tween miRNA and its target RNA is needed to trigger the
gene silencing eﬀect, this approach may be superior to cur-
rent small molecule drugs since the high rate of HIV mu-
tations often produce resistance to such agents. Northern
blot analysis in Figure 5(a) demonstrated the ex vivo gene si-
lencing eﬀect of anti-HIV miRNA transfection (n = 3f o r
each set) on HIV-1 replication in CD4+ Tl y m p h o c y t e sf r o m
both acute and chronic phase AIDS patients. In the acute
phase (≤ one month), the 50nM miRNA vector transfec-
tion degraded an average of 99.8% of the viral RNA genome
(lane 4), whereas the same treatment knocked down only
an average of 71.4 ± 12.8% of viral genome replication in
the chronic phase (about a 2-year infection). Immunocy-
tochemical staining for HIV p24 marker protein conﬁrmed
the results of Northern blot analysis (Figure 5(b)). Sequenc-
ing analysis has revealed at least two HIV-1b mutations in
the acute phase and seven HIV-1b mutations in the chronic
phase within the targeted HIV genome domain. It is likely
that the higher genome complexity produced by HIV muta-
tions in chronic infections reduces miRNA-mediated silenc-
ing eﬃcacy. Transfection of 50nM miRNA∗ vector homolo-
gous to the HIV-1 genome failed to induce any RNAi eﬀect
on the viral genome, indicating the speciﬁcity of the miRNA
eﬀect(lane5).Expressionofthecellularhouse-keepinggene,
β-actin,wasnormalandshowed no interferon-inducednon-
speciﬁc RNA degradation. These results suggest that the de-
signed anti-HIV SpRNAi-RGFP vector is highly speciﬁc and
eﬃcient in suppressing HIV-1 replication in early infections.
In conjunction with an intermittent interleukin-2 therapy
[55], the growth of noninfected CD4+ Tl y m p h o c y t e sm a y
be stimulated to eliminate the HIV-infected cells.
CONCLUSION
The consistent evidence of miRNA-induced gene silencing
eﬀects in zebraﬁsh, chicken embryos, mouse stem cells, and
human disease demonstrates the preservation of an ancient
intron-mediated gene regulation system in eukaryotes. In
theseanimalmodels,theintron-derivedmiRNAproducesan
RNAi-like gene silencing eﬀect. We herein provide the ﬁrstShi-Lung Lin et al 11
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Figure 5: Silencing of HIV-1 genome replication using anti-gag/pro/pol miRNA transfection into CD4+ T lymphocytes isolated from the
acute and chronic phases of AIDS infections. (a) Northern blot analysis showed about 98% and 70% decreases of HIV genome in the acute
and chronic infections after miRNA treatments (lane 4), respectively. No eﬀect was detected inthe Tcells transfected withmiRNA∗ targeting
the same gag/pro/pol region of the viral genome (lane 5). The size of pure HIV-1 provirus was about 9,700 nucleotide bases (lane 1). RNA
extracts from normal noninfected CD4+ T lymphocytes were used as a negative control (lane 2), whereas those from HIV-infected T cells
were used as a positive control (lane 3). (b) Immunostaining for HIV p24 marker conﬁrmed the results in (a). Since the ex vivo HIV-silenced
T lymphocytes were resistant to any further infection by the same strains of HIV, they may be transfused back to the donor patient for
eliminating HIV-infected cells.
evidence for the biogenesis and function of intronic miRNA
in vivo. Given that evolution has given rise to more com-
plexity and more variety of introns in higher animal and
plant species for the task of coordinating their vast gene
expression libraries and interactions, dysregulation of these
miRNAs due to intronic expansion or deletion will likely
cause genetic diseases, such as myotonic dystrophy and frag-
ile X mental retardation. Thus, gene expression produces
not only gene transcripts for its own protein synthesis but
also intronic miRNA, capable of interfering with the expres-
sion of other genes. Thus, the expression of a gene results
in gain-of-function of the gene and also loss-of-function of
other genes, with complementarity to the mature intronic
miRNA. An array of genes can swiftly and accurately coordi-
nate their expression patterns through the mediation of their
intronic miRNAs, bypassing the time-consuming transla-
tion process in quickly changing environments. Conceivably,
intron-mediated gene regulation may be as important as the
mechanisms by which transcription factors regulate gene ex-
pression. It is likely that intronic miRNA is able to trigger
cell transitions quickly in response to external stimuli with-
out such tedious protein synthesis. Undesired gene products
are reduced by both transcriptional inhibition and/or trans-
lational suppression via miRNA regulation. This could en-
able a rapid switch to a new gene expression pattern with-
out the need to produce various transcription factors. This
regulatory property of miRNAs may have modulated an-
cient gene even before the emergence of proteins in the post-
RNA world. Considering the variety of microRNAs and the
complexity of genomic introns, a thorough investigation of
miRNA variants in the human genome will markedly im-
prove the understanding of genetic diseases and also the de-
sign of miRNA-based drugs. Learning how to exploit such a
novel gene regulation system for future therapeutic applica-
t i o n sw i l lb eag r e a tc h a l l e n g e .
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